Page last updated: 2024-10-26

diphenyleneiodonium and Obesity

diphenyleneiodonium has been researched along with Obesity in 1 studies

diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Talior, I1
Tennenbaum, T1
Kuroki, T1
Eldar-Finkelman, H1

Other Studies

1 other study available for diphenyleneiodonium and Obesity

ArticleYear
PKC-delta-dependent activation of oxidative stress in adipocytes of obese and insulin-resistant mice: role for NADPH oxidase.
    American journal of physiology. Endocrinology and metabolism, 2005, Volume: 288, Issue:2

    Topics: Adipocytes; Animals; Cells, Cultured; Dietary Fats; Dose-Response Relationship, Drug; Enzyme Activat

2005